Literature DB >> 1923372

The Beaver Dam Eye Study: visual acuity.

R Klein1, B E Klein, K L Linton, D L De Mets.   

Abstract

Few current population-based data on visual impairment are available. Visual acuity and impairment were measured in 4926 people between the ages of 43 and 86 years in the defined population participating in the Beaver Dam Eye Study. Visual acuity was measured after refraction, using standardized protocols. Of a possible maximum score of 70 (20/10), the mean number of letters correctly identified (right eye) varied from 55.7 (20/20, n = 1515) in people between the ages of 43 and 54 years to 41.2 (20/40, n = 795) in people 75 years of age or older. Age-specific mean visual acuity scores were consistently and significantly lower in women, who identified three fewer letters on the average than men. Rates of any visual impairment (20/40 or worse in the better eye) or legal blindness (20/200 or worse in the better eye), increased from 0.8% and 0.1%, respectively, in people between the ages of 43 and 54 years to 21.1% and 2.0%, respectively, in people 75 years of age or older. Multivariate analyses showed both sex (women) and age (older) to be significant and independent predictors of poorer visual acuity.

Entities:  

Mesh:

Year:  1991        PMID: 1923372     DOI: 10.1016/s0161-6420(91)32137-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  178 in total

Review 1.  World blindness: a 21st century perspective.

Authors:  H R Taylor; J E Keeffe
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  Correction of refractive error in the Victorian population: the feasibility of "off the shelf" spectacles.

Authors:  R Maini; J Keeffe; L A Weih; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

3.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

4.  Visual acuity measurements in a national sample of British elderly people.

Authors:  J C van der Pols; C J Bates; P V McGraw; J R Thompson; M Reacher; A Prentice; S Finch
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

5.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Authors:  Sudha K Iyengar; Danhong Song; Barbara E K Klein; Ronald Klein; James H Schick; Jennifer Humphrey; Christopher Millard; Rachel Liptak; Karlie Russo; Gyungah Jun; Kristine E Lee; Bonnie Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

6.  Associations of selected medications and visual function: the Beaver Dam Eye Study.

Authors:  B E K Klein; R Klein; M D Knudtson; K E Lee; L G Danforth; J O Reinke; A M Adler
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

7.  Retinopathy in a population-based study.

Authors:  R Klein
Journal:  Trans Am Ophthalmol Soc       Date:  1992

8.  Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration.

Authors:  Gwenole Quellec; Stephen R Russell; Johanna M Seddon; Robyn Reynolds; Todd Scheetz; Vinit B Mahajan; Edwin M Stone; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

9.  Parents' attained age and biomarkers of aging in their children.

Authors:  Barbara E K Klein; Michael D Knudtson; Kristine E Lee; Ronald Klein
Journal:  Arch Gerontol Geriatr       Date:  2008-12-13       Impact factor: 3.250

10.  Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.